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Whittemore et al,2 in their seminal paper in 1981, demon-
strated 5-year patency rates in excess of 85% when vein
graft lesions were prophylactically revised, but less than
40% for lesions that were repaired in conjunction with
graft thrombectomy. Veith et al8 further demonstrated
that limb ischemia recurred in more than 80% of the cases
after infrainguinal graft thrombosis. Belkin et al10,11
reconfirmed the conclusions of Whittemore and Veith by
demonstrating that attempts should be made to identify
stenotic lesions before vein graft failure because most
thrombosed grafts will not maintain long-term patency
after thrombectomy, despite subsequent revision. Despite
these reports, the optimal frequency of duplex scanning-
based surveillance and the criteria for vein graft revisions
still vary among surgeons.
Secondary procedures that can be used as a means of
“correcting” graft stenosis have been used with varied suc-
cess; they include excision with primary anastomosis, vein
patch angioplasty, interposition grafting, sequential or
jump grafting, and, recently, percutaneous transluminal
angioplasty.12-19 No consensus exists about the best sec-
ondary procedure for focal post-implantation occlusive
disease. In addition, the outcome of graft revision may dif-
fer depending on the morphologic features of the lesions
or their locations.
In this study, we detail our experience with infrain-
guinal arterial reconstructions performed with venous
Autogenous vein is accepted as the optimal conduit for
infrainguinal arterial reconstruction. Regardless of the type
of revascularization (in situ versus excised vein), a diligent
surveillance program will not only improve secondary
patency, but will also increase overall limb-salvage rates.1-7
In the past, post-bypass grafting evaluation involved
clinical examination, evaluation of distal pulses, and pulse
volume recordings.8,9 However, these tests are not suffi-
ciently sensitive means of detecting many pre-occlusive
graft stenoses. Recently, duplex scanning has been used for
surveillance and has been a means of providing additional
information about the long-term natural history of venous
conduits used as arterial bypass grafts. With this tech-
nique, Bandyk et al6 demonstrated that 68% of patients
with pre-occlusive vein graft stenoses had no symptoms.
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Purpose: Infrainguinal arterial reconstruction with vein as the conduit has been regarded as the gold standard within
the past two decades. However, as many as 20% of patients undergoing these bypass grafting procedures may need sec-
ondary interventions for continued patency. Once these reconstructions have been altered, there is concern about the
continued patency of these types of revascularizations. In this study, we evaluated the long-term patency of venous
reconstructions that had been revised, compared them with those bypass grafting procedures that did not require any
intervention, and analyzed long-term outcome.
Methods: In the past 15 years, 3944 infrainguinal arterial reconstructions were completed with vein as the conduit. A
total of 2780 were performed with the vein in situ, and 1164 were performed by using excised vein in a single piece
or spliced configuration. Indication, risk factors, and patient demographics were evaluated. Grafts were stratified into
revised and unrevised, in situ and excised; excised vein was then stratified into spliced and non-spliced. All grafts were
followed with duplex ultrasound scans performed at 3, 6, and 12 months in the first year and every 6 months there-
after. Statistical analysis was performed by using Gehan’s generalized Wilcoxon test.
Results: Demographics and indications were similar between groups. Nine percent of all excised veins required some
revision, compared with 10% of all in situ reconstructions. When the excised veins were further stratified, 6% of single-
piece venous conduits were revised, as opposed to 14% of reconstructions with spliced venous reconstruction. The 
5-year patency rates were 67% for revised reconstructions and 78% for unrevised reconstructions (P < .0001). The 
5-year patency rate of unrevised in situ bypass grafts was 81%, as compared with 69% for revised in situ reconstruction
(P < .0001), and the 5-year patency rate for unrevised excised veins was 68%, with revised excised vein having a 5-year
patency rate of 59% (P = not significant).
Conclusion: Venous conduits that require revision have a significantly lower long-term patency rate than those that were
unrevised. Grafts that require revision may be best suited for aggressive surveillance protocol to maximize long-term
patency. (J Vasc Surg 2002;35:773-8.)
conduit. The results and long-term follow-up of patients
who had revised conduits are compared with patients who
had these types of reconstructions and did not require
revision.
METHODS AND MATERIALS
From 1986 to 1998, 334 bypass grafts underwent 414
revisions. These bypass grafts were performed by using the
in situ technique preferentially. When an in situ revascu-
larization was not possible, an excised single- or spliced-
vein reconstruction was performed. Data were entered
prospectively into a computerized Vascular Registry. The
method of vein preparation of the conduit has been
described.20,21 Postoperatively, patients were examined at
least every 3 months for 1 year and every 6 months there-
after. The method of postoperative evaluation included
clinical examination, postoperative pulse volume record-
ing, and duplex ultrasound scanning. Any deterioration in
the clinical status of the lower extremity in question or
change in the pulse volume recordings that was manifested
by means of alterations in the contour of arterial wave-
forms or segmental pressures at any measured level
prompted further investigation. Early in our experience,
duplex scanning surveillance was performed with a 10-
MHz mechanical sector transducer equipped with a 4.5-
MHz pulsed Doppler scanner. Currently, a 10-MHz or a
7-MHz linear array transducer equipped with a 4-MHz
pulsed Doppler scanner is used. Color imaging required
the use of linear array transducers. Evaluations of the
entire bypass graft and the inflow and outflow arteries
were performed. Measurements of volume flow and peak
systolic velocities were recorded. A stenosis greater than a
50% diameter reduction as manifested by means of dou-
bling of peak systolic velocity along the conduit or signif-
icant reduction in flow prompted further inquiry. In some
cases, biplanar contrast angiography was used as a means
of both confirming and further delineating the suspected
lesion in preparation for intervention. Angiography was
not performed when the lesion was obvious and hemody-
namically significant. An example would be an identified
valve leaflet. When the lesion was not well defined,
angiography was always performed. All hemodynamically
significant stenoses confirmed by means of angiography
were repaired, unless other factors prevented operative
intervention.
The primary and secondary patency, limb-salvage,
operative revision, and survival rates were recorded
prospectively in a computerized vascular registry. This
was expressed by using Kaplan-Meier methods. All data
presented in this manuscript demonstrated an SE of less
than 10%. The revisions were analyzed by means of the
site of occurrence, type of conduit (in situ versus
reversed vein), time of occurrence of the stenosis, type
of repair, length of bypass graft, and size of in situ vein,
and results were compared with those of unrevised
bypass grafts. Statistical analysis was performed by using
Gehan’s generalized Wilcoxon test, an extension of the
log-rank test for outcomes. Chi-square analysis was used
for categorical variables. Significance was assumed for P
values less than .05.
RESULTS
In the past 15 years, 3944 arterial reconstructions
with vein have been performed; 414 revisions were
required in 334 of these bypass grafts (8%). For compari-
son, 340 bypass grafts were done with a prosthetic conduit
in this same period. Sixty-two percent of patients were
men, 50% had diabetes mellitus, and 34% were smokers.
The mean age of patients was 69 years (range, 19-100
years). The mean follow-up period was 25.2 ± 0.55
months (SE). Patient demographics were similar in both
the revised and un-revised bypass graft groups. The indi-
cations for surgery are listed in Table I. They are similar in
both groups, except more revised bypass grafts were done
for rest pain (37% vs 28%). Inflow arteries in the two
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Table I. Indications for surgery
Revised bypass Unrevised bypass
Indication grafts (%) grafts (%)
Claudication 13 (3.9) 246 (6.8)
Microembolic 4 (1.2) 41 (1.1)
Rest pain* 124 (37.1) 1013 (28.1)
Ulcer 113 (33.8) 1287 (35.7)
Gangrene 65 (19.5) 870 (24.1)
Trauma 3 (0.9) 72 (2.0)
Aneurysm 12 (3.6) 81 (2.2)
*Statistically significant difference.
Table II. Inflow source
Revised bypass Unrevised bypass
Inflow grafts (%) grafts (%)
Graft/iliac 32 (9.6) 294 (8.1)
Common femoral 108 (32.3) 1130 (31.3)
Superficial femoral 104 (31.1) 1177 (32.6)
Profunda femoral* 75 (22.5) 632 (17.5)
Popliteal* 14 (4.2) 319 (8.8)
Tibial 1 (0.3) 58 (1.6)
*Statistically significant difference.
Table III. Outflow arteries
Revised bypass Unrevised bypass
Outflow grafts (%) grafts (%)
Popliteal* 97 (29.0) 1424 (39.0)
Tibialperoneal trunk 10 (3.0) 67 (1.9)
Anterior tibial 59 (17.6) 569 (15.7)
Dorsalis pedis 31 (9.3) 337 (9.3)
Posterior tibial 61 (18.3) 663 (18.4)
Peroneal 76 (22.8) 938 (26.0)
*Statistically significant difference.
groups are listed in Table II. The outflow artery was most
often the popliteal, with the remainder being tibial or
pedal reconstructions in both groups (Table III).
Revisions by type and location are listed in Table IV. Ten
percent of the in situ reconstructions, 7% of the single
excised vein bypass grafting procedures, and 14% of the
spliced-vein procedures required revision. Seventy-seven
conduits required proximal inflow revision, 101 required
distal outflow revision, 64 required proximal vein, 78
required mid-vein, and 60 required distal vein revisions.
Twenty-seven patients required vein graft thrombectomy
and revision. A total of 270 revisions were performed with
interposition bypass grafts, 108 with vein patch, and nine
were repaired directly. Seventy percent of patients were
treated with in situ saphenous vein reconstruction, and
26% had excised vein reconstruction; of the latter group,
70% were single excised vein and 30% were spliced-vein
reconstructions (Table V). Bypass graft patency rates for
revised bypass grafts at 1, 3, and 5 years were 81%, 73%, and
67%, respectively, and for unrevised bypass grafts were 89%,
84%, and 78% (P < .0001), respectively. Table VI lists the
different parameters evaluated in this series and notes 
the statistical significance between groups analyzed. For the
patients undergoing in situ bypass grafting, distal vein size
was recorded; 9.3% had veins smaller than 3 mm, 27% had
veins that were 3 to 3.4 mm, and 64% had veins larger than
3.5 mm (Table VII). Two hundred-sixty limbs had one
revision, 66 limbs required two revisions, six limbs required
three revisions, and one limb required four revisions.
Patient survival rates for the unrevised bypass graft group at
1, 3, and 5 years were 86%, 72%, and 60%, respectively,
and for the revised bypass graft group were 92%, 87%, and
77%, respectively (P = .0003). Patients who underwent
revisions had significantly increased survival rates. This
may be because this group was the healthier group and
reoperation was freely considered. Alternatively, these
patients were more faithful in follow-up with our group
and other physicians, resulting in a more supervised health
care with better longevity. Limb-salvage rates were similar
in both groups, with patients undergoing unrevised bypass
grafting procedures having 1-, 3-, and 5-year limb-salvage
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rates of 96%, 95%, and 94%, respectively, as compared with
96%, 92%, and 90%, respectively, for revised bypass graft-
ing procedures. When looking at the lengths of bypass
grafts, we found that all bypass grafts that originated
within 10 cm of the femoral bifurcation and ended within
10 cm of the malleolus were considered to be “long”
bypass grafts. Unrevised long bypass grafts had 1-, 3-, and
5-year patency rates of 88%, 81%, and 77%, respectively, as
opposed to revised bypass grafts, which had 5-year patency
rates of 78%, 65%, and 65%, respectively (P < .0001). 
In patients who had revisions within 3 months, 1-, 3- and
5-year patency rates were 58%, 52%, and 52%, respectively,
as compared with 91%, 84%, and 80%, respectively, for
revisions occurring more than 4 months after the initial
bypass grafting procedure. This was highly statistically sig-
nificant (P < .0001). These results are listed in Table VIII.
As the size of the vein conduit decreased, the percentage
of revisions performed increased from 8% in veins longer
than 3.5 mm to 12% in veins shorter than 3 mm (P < .05;
Table IX).
DISCUSSION
The concept of the “failing graft” is a well-known clin-
ical entity that depicts a bypass grafting conduit that is
threatened by a hemodynamically significant lesion.
Despite refinement in surgical technique, approximately
20% to 30% of these reconstructions will develop lesions
during the life of their bypass graft, threatening subse-
quent patency of the venous conduit.22,23 The importance
of recognition of the failing bypass graft lies in the knowl-
edge that a significant number of these reconstructions
Table IV. Revision by type and location
Bypass graft 
Type/location Proximal inflow Proximal vein Mid-vein Distal vein Distal outflow thrombectomy
Total 77 64 78 67 101 27
Bypass grafting
Artery to bypass graft 53 11 0 0 0
Bypass graft to bypass graft 6 26 50 20 1
Bypass graft to artery 3 0 0 2 98
Patch
Artery to bypass graft 6 2 0 0 0
Bypass graft to bypass graft 6 24 25 43 2
Direct repair
Artery to bypass graft 2 0 0 0 0
Bypass graft to bypass graft 1 1 3 2 0
Table V. Type of reconstruction
Type Revised (%) Unrevised (%)
In situ 246 (73.7) 2535 (70.2)
Single excised vein* 44 (13.2) 749 (20.7)
Spliced vein* 44 (13.2) 325 (9.1)
*Statistically significant difference.
will progress to actual failure with conduit thrombosis if
early intervention is not performed. The use of a regular
surveillance program as a means of detecting pre-occlusive
hemodynamically significant lesions allows for revision
before bypass graft failure.1-7,12-19 However, the necessary
frequency and overall length of surveillance and postoper-
ative follow-up remains controversial. Several centers have
advocated less intense surveillance when no hemodynami-
cally significant abnormalities are revealed by means of
studies performed within the first 3 to 6 months postop-
eratively.24,25 Mills et al5 evaluated the results of frequent
surveillance after in situ, ectopic, and spliced vein bypass
grafting procedures and found stenosis progression to
occur in 45% of bypass grafts with abnormal results on
early scans. However, only 2.2% of bypass grafts with nor-
mal scan results within 3 months of operation subse-
quently developed a significant stenosis requiring revision.
Similarly, Mohan et al26 reviewed surveillance data after in
situ bypass grafting procedures performed in 219 patients.
Abnormalities in postoperative duplex scans were found in
32% of bypass grafts within 6 months. However, operative
revision was necessary for subsequent abnormalities found
by means of duplex scanning in only 2% of the bypass
grafts with normal results on scans performed within the
first 6 months of surgery. These data differ from those of
this study, by means of which 22% of abnormalities dis-
covered by means of duplex scanning were demonstrated
to occur more than 2 years after bypass grafting. In addi-
tion, 15% of the revised group of bypass grafts developed
de novo lesions on duplex scanning examination more
than 2 years after bypass grafting reconstruction.
Reifsnyder et al27 have demonstrated that more than 50%
of venous conduits will develop evidence of atherosclerotic
degeneration and significant lesions beyond 5 years. In a
larger study involving long-term surveillance of in situ
bypass grafts, Erikson et al25 showed that lesions amenable
to surgical revision continued to occur years after arterial
reconstruction. These authors recommended extensive
long-term, if not life-long, surveillance. A large number of
revisions in our series (49%) occurred within 6 months
after the initial bypass grafting procedure. However, 32%
of inflow, 23% of outflow, and 18% of venous-conduit revi-
sions (not including ligation of arterial venous fistulas or
retained valves) occurred more than 2 years after con-
struction of the original bypass graft. Although the fre-
quency of detected lesions appeared to diminish as the
length of surveillance increased, a number of lesions will
still develop and still require revision beyond a 2-year
postoperative period. Thus, our data demonstrate that
significant lesions developed throughout all periods of fol-
low-up in this study, supporting the concept that bypass
graft surveillance should continue indefinitely. When look-
ing at the patency of these revised reconstructions, we
must acknowledge that the long-term outcome is still not
as good as those unrevised reconstructions. When further
stratified, we can demonstrate that spliced vein recon-
structions, reconstructions that required early revision, or
reconstructions in patients who underwent secondary
operations were the most likely to be revised, having lower
but acceptable long-term patency rates. Despite this, limb-
salvage rates in all groups appeared adequate, although
numerous interventions were required in some disadvan-
taged conduits. Because of this, we fix all hemodynami-
cally significant confirmed lesions whenever possible.
Gentile et al22 demonstrated that tibial reconstruction
with alternative vein sources required revision in about
30% of bypass grafts, as opposed to 12% of bypass grafts in
greater saphenous veins. They concluded that similar
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Table VI. Patency of revised and unrevised bypass grafts
Bypass graft 30 day Year 1 Year 3 Year 5
Unrevised bypass grafts 0.952 0.891 0.836 0.775
P < .0001Revised bypass grafts 0.909 0.813 0.725 0.674
Unrevised in situ 0.962 0.913 0.866 0.814
P < .0001Revised in situ 0.889 0.813 0.728 0.692
Unrevised excised veins 0.926 0.838 0.765 0.679
P = .97Revised excised veins 0.966 0.811 0.716 0.591
Unrevised long bypass grafts 0.947 0.884 0.812 0.766
P < .0001Revised long bypass grafts 0.903 0.777 0.652 0.652
Table VII. Distal vein size in in-situ bypass grafts
Vein size 30 day Year 1 Year 3 Year 5
Unrevised vein < 3.0 mm 0.894 0.765 0.700 0.626
P = .36Revised vein < 3.0 mm 0.837 0.753 0.656 0.656
Unrevised vein 3.0-3.4 mm 0.957 0.893 0.827 0.772
P < .0001Revised vein 3.0-3.4 mm 0.849 0.716 0.680 0.636
Unrevised vein > 3.4 mm 0.969 0.929 0.886 0.839
P < .001Revised vein > 3.4 mm 0.923 0.864 0.761 0.700
patency rates can be obtained by using alternative vein
sources when compared with greater saphenous vein. In
this study, even in patients with limited venous conduits,
the overall outcome as measured by means of limb-salvage
rates was excellent, and this may be because of diligent
postoperative surveillance, aggressive surgical interven-
tion, and the use of unconventional forefoot amputations.
The group of patients who had significantly worse
results were those who had early revision (<3 months after
original bypass grafting procedure). The 3-year patency
rate of these reconstructions was 52%, compared with 86%
in patients whose bypass grafts were revised after 3 months
(P < .001). This may be because of unrecognized preex-
isting vein disease or a more aggressive neointimal hyper-
plastic response.28 All groups that had a statistically
significant decrease in patency rates demonstrated the
greatest loss within the first year after revision. These data
corroborate studies by Belkin and Robinson, who demon-
strated that secondary reconstructions and revisions in
patients who had early bypass graft failure (<3 months)
had an outcome that was significantly worse than patients
who had later failure.10-12
From this experience, we have learned that reconstruc-
tions that do not require any intervention will do better
than those that have been revised. Patients with limited
venous conduit, damaged venous conduit, or reconstruc-
tion options that require segmental replacement of vein
tended to have more revisions, closer follow-up, and more
aggressive intervention than those patients with a single-
vein conduit to maintain similar patency. Bypass grafts that
were revised are at greater risk for subsequent revision to
maintain patency. Thus, instead of lumping all reconstruc-
tions in the same surveillance program, one may consider
placing each type of these reconstructions in a different
protocol. We may suggest that after 2 years, the interval for
duplex surveillance in an unrevised revascularization
should remain at 6 months to a year to pick up any de novo
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lesions, and those patients who have had revision should be
more rigorously examined by means of duplex ultrasound
scanning during the first 2 years after that revision.
CONCLUSION
Long-term surveillance data from this study and oth-
ers demonstrate that a substantial number of hemody-
namically significant lesions can develop in infrainguinal
reconstructions performed with venous conduit at any
time after the original operation. These lesions may
require surgical intervention to prolong the life of the
bypass graft. Thus, maximizing limb salvage in this popu-
lation of patients may require diligent life-long duplex
scanning surveillance and aggressive intervention to max-
imize patency and limb salvage.
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